BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Dec 15, 2025; 16(12): 115435
Published online Dec 15, 2025. doi: 10.4239/wjd.v16.i12.115435
From fatty liver indices to the Zhejiang University index: Re-shaping risk stratification of metabolic liver disease in diabetes
Mostafa M Gouda
Mostafa M Gouda, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou 310027, Zhejiang Province, China
Mostafa M Gouda, Department of Nutrition and Food Science, National Research Centre, Giza 12622, Egypt
Author contributions: Gouda MM contributed to conceptualization, methodology, literature search, figure building, and original draft writing sections.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mostafa M Gouda, PhD, Professor, College of Biosystems Engineering and Food Science, Zhejiang University, No. 866 Yuhangtang Road, Hangzhou 310027, Zhejiang Province, China. mostafa-gouda@zju.edu.cn
Received: October 16, 2025
Revised: November 8, 2025
Accepted: November 18, 2025
Published online: December 15, 2025
Processing time: 59 Days and 20.4 Hours
Core Tip

Core Tip: Early identification of metabolic dysfunction-associated steatotic liver disease (MASLD) in diabetes requires reliable and easily applicable tools. The Zhejiang University index (ZJU index) combines metabolic and hepatic parameters, such as body mass index, fasting glucose, triglycerides, and enzyme ratios, into a simple score derived from routine clinical data. Unlike traditional indices such as fatty liver index and hepatic steatosis index, the ZJU index demonstrates superior accuracy for detecting MASLD and correlates with systemic complications, including insulin resistance and sarcopenia. Its integration into electronic medical records enables automatic annual screening of patients with type 2 diabetes mellitus, providing a cost-effective, non-invasive approach for risk stratification and guiding timely preventive interventions.